Florida Cancer Specialists & Research Institute Joins Statewide FLASCO Gathering to Address Current and Future Changes in Cancer Care Delivery

Fort Myers, Fla., October 28, 2022 – Physicians, clinicians and senior leaders of Florida Cancer Specialists & Research Institute, LLC (FCS) will continue their long history of active involvement with the Florida Society of Clinical Oncology (FLASCO) at the FLASCO Fall Session being held in Orlando, Oct. 28 & 29.  The gathering of medical oncologists, hematologists, nurse practitioners, pharmacists and other health care professionals who manage and provide care for cancer patients across the state will feature dynamic educational tracks that focus on the latest scientific advancements in cancer care, the effects of novel therapies and barriers to care.

Diane Cope, PhD, APRN, BC, AOCNP, FCS Director of Nursing, will participate as a panelist for “The Expanding Role of the Oncology Nurse.” The session will explore post-COVID patient care, insurance navigation, advance care planning and overcoming barriers to care.

Kayla Haines, MSN, APRN, FNP-C, an FCS advanced practice provider, will participate as a panelist for a general session on Lung Cancer Solid Tumor.

FCS President & Managing Physician Michael Diaz, MD, who served as FLASCO president from 2015 to 2017, said, “FLASCO fosters multidisciplinary collaboration, which is critical in the complex field of oncology. Our active participation in this premier statewide network helps to ensure that we are learning, sharing best practices and finding solutions together with our colleagues from across the state.”

“As a leader in community oncology care and research, we are proud to share our voices and experiences to continuously improve patient outcomes and the overall experience for oncology patients,” said FCS Chief Executive Officer Nathan H. Walcker.

The following FCS medical oncologists currently serve in leadership roles on the FLASCO Board of Directors:

• Maen Hussein, MD – Vice President
• Richard McDonough, MD – Past President and Volunteer Director of Fellows Programs
• Barry Berman, MD, MS – Finance Committee Chair
• Michael Diaz, MD – Past President and Director of Patient Advocacy and Federal Legislative Committee
• Eric Harris, DO – Program Committee Chair
• Faithlore Gardner, MD – Clinical Practice Co-Vice Chair
• Scott Tetreault – Legislative State & Federal Vice Chair
• Jennifer Cultrera, MD – Fellowship/President Outreach Program Co-Chair

Also serving on the FLASCO Board of Directors are FCS Chief Medical Officer of Therapeutics & Analytics Lucio Gordan, MD and medical oncologists Nalini Hasija, MD, Sachin Kamath, Paresh Patel, MD, Cesar Perez, MD, MD and FCS Director of Pharmacy Operations Kristen Boykin, PharmD, BCOP, BCPS.

The Florida Society of Clinical Oncology (FLASCO) is a member-supported statewide non-profit organization committed to facilitating and promoting multidisciplinary efforts for oncology practitioners and industry professionals to improve patient care in Florida.